{"title":"基因组学使前列腺癌个人化","authors":"A. Kulkarni, M. Wafik","doi":"10.1002/tre.883","DOIUrl":null,"url":null,"abstract":"Advances in genomics are enabling the early recognition of hereditary prostate cancer with important diagnostic and prognostic implications, helping with access to personalised targeted therapies and opportunities for early cancer detection and prevention.","PeriodicalId":42819,"journal":{"name":"Trends in Urology & Mens Health","volume":"5 1","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genomics makes prostate cancer personal\",\"authors\":\"A. Kulkarni, M. Wafik\",\"doi\":\"10.1002/tre.883\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Advances in genomics are enabling the early recognition of hereditary prostate cancer with important diagnostic and prognostic implications, helping with access to personalised targeted therapies and opportunities for early cancer detection and prevention.\",\"PeriodicalId\":42819,\"journal\":{\"name\":\"Trends in Urology & Mens Health\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Urology & Mens Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/tre.883\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Urology & Mens Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tre.883","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Advances in genomics are enabling the early recognition of hereditary prostate cancer with important diagnostic and prognostic implications, helping with access to personalised targeted therapies and opportunities for early cancer detection and prevention.